Stockreport

Arrowhead Pharmaceuticals Teases 2026 Catalysts, Waylivra Launch Momentum at TD Cowen Conference [Yahoo! Finance]

Arrowhead Pharmaceuticals, Inc.  (ARWR) 
Last arrowhead pharmaceuticals, inc. earnings: 2/5 04:00 pm Check Earnings Report
US:NASDAQ Investor Relations: ir.arrowheadpharma.com/investor-relations
PDF from SHASTA-3/4 evaluating plozasiran in severe hypertriglyceridemia (Q3 2026), CSF tau knockdown data for its CNS program ARO-MAPT (late Q3/early Q4), plus additional d [Read more]